Huiyu Pharmaceutical: Shanghai Shuangsai plans to reduce its holdings in the company by no more than 2.997%.

Huayu Pharmaceutical announced on the evening of May 11 that Shanghai Shuangsai Enterprise Management Consulting Co., Ltd., a shareholder holding 2.997% of the company's shares, plans to reduce its holdings by no more than 12.69 million shares, or 2.997% of the total share capital of the company.